I-FABP levels correlated with disease severity and clinical outcomes in patients with necrotizing enterocolitis, mesenteric ischemia, hemorrhagic shock, cardiogenic shock, HIV infection, COVID-19, and septic shock, as well as in critically ill ICU patients [11,36,37,38,39,40]. This evidence concerns the gene FABP2 and necrotizing enterocolitis.